XETRA

EQS-News: beaconsmind Group: First Berlin continues to rate beaconsmind share as 'Buy' – Price target EUR 14.00

Retrieved on: 
Wednesday, April 10, 2024
EUR, Software as a service, Wi-Fi, XETRA, CHF, Ticker, Gesellschaft mit beschränkter Haftung

The rating for beaconsmind stock remains unchanged at "Buy" with a target price of EUR 14.00.

Key Points: 
  • The rating for beaconsmind stock remains unchanged at "Buy" with a target price of EUR 14.00.
  • With this target price, First Berlin sees significant price potential of approximately 190%.
  • According to First Berlin, future M&A activities, among other things, are not yet sufficiently reflected in the current price level.
  • The current report by First Berlin on beaconsmind is available for download on the corporate website of beaconsmind www.beaconsmind.com in the "Investor Relations" section.

EQS-News: Newron presents 2023 financial results and provides 2024 outlook

Retrieved on: 
Wednesday, April 10, 2024
Psychosis, Schizophrenia, Clozapine, XETRA, Patient, CNS, Business development, Peripheral nervous system, Psychedelic literature, Safety, TRS, PANSS, EIB, Canadian International Council, Pharmaceutical industry

Milan, Italy, March 19, 2024, 07:00 am CET – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced its financial results and operational highlights for the business year ended December 31, 2023, and provided an outlook for 2024.

Key Points: 
  • Milan, Italy, March 19, 2024, 07:00 am CET – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced its financial results and operational highlights for the business year ended December 31, 2023, and provided an outlook for 2024.
  • Results from the first 100 patients to complete six months (30 weeks) of treatment with evenamide were reported in January, followed by results in February 2023 from the same 100-person cohort at the one-year (52 weeks) timepoint.
  • These data were further strengthened, post-period in January 2024, with the final results from study 015 reviewing all study participants after one year of treatment.
  • Patient enrollment has completed and results from this study are expected in April 2024.

EQS-News:  Newron enters into an agreement for the subscription of up to 2.05 million newly issued shares; Proceeds of up to EUR 15.0 million 

Retrieved on: 
Wednesday, April 10, 2024
EUR, Frankfurt Stock Exchange, XETRA, CFO, Patient, CNS, SIX Swiss Exchange, Peripheral nervous system, Security (finance)

Newron enters into an agreement for the subscription of up to 2.05 million newly issued shares; Proceeds of up to EUR 15.0 million

Key Points: 
  • Newron enters into an agreement for the subscription of up to 2.05 million newly issued shares; Proceeds of up to EUR 15.0 million
    The issuer is solely responsible for the content of this announcement.
  • Under the agreement, the fund subscribes to an initial 750,000 newly issued shares at a subscription price of EUR 7.33 per share, which corresponds to gross proceeds of approximately EUR 5.5 million.
  • In addition, the fund has a right to subscribe to an additional up to 1,300,000 newly issued shares until no later than January 31, 2025, at a subscription price to be calculated pursuant to an agreed formula.
  • “The investment by this specialist institutional fund is a validation of our strategy to develop innovative CNS therapies,” said Roberto Galli, CFO of Newron.

EQS-News: Newron announces agreement with the European Investment Bank (EIB) to extend the near-term tranche repayment dates of its 2018 financing agreement

Retrieved on: 
Wednesday, April 10, 2024
EIB, Peripheral nervous system, Patient, CNS, Schizophrenia, XETRA, European Investment Bank, BofA Securities, Pharmaceutical industry

Under the amendment, repayment of tranches one to three (out of a total of five) of the financing agreement with due dates from June 2024 to April 2025 will be shifted substantially, with tranche one now scheduled for November 25, 2025, tranche two for April 2026 and tranche three for June 2026.

Key Points: 
  • Under the amendment, repayment of tranches one to three (out of a total of five) of the financing agreement with due dates from June 2024 to April 2025 will be shifted substantially, with tranche one now scheduled for November 25, 2025, tranche two for April 2026 and tranche three for June 2026.
  • The due dates for tranches four and five will stay unchanged.
  • On the amended tranches, Newron will start paying the agreed interest rates.
  • Details of the 2018 loan agreement can be found in Newron’s 2022 Annual Report which is posted on its website.

EQS-News: SMC Research upgrades NAGA to “Speculative BUY” with significant upside potential on back of imminent merger with Capex.com

Retrieved on: 
Wednesday, April 10, 2024
Research, EUR, EGM, VISA, XETRA, SMC, News, Investment, Fiat, Research report, Cryptocurrency

NAGA is an innovative fintech company that seamlessly connects personal finance transactions and investments through its social proprietary trading platform.

Key Points: 
  • NAGA is an innovative fintech company that seamlessly connects personal finance transactions and investments through its social proprietary trading platform.
  • The company's platform offers a range of products from stock trading, investments and cryptocurrencies to a physical VISA card.
  • Additionally, the platform allows for exchanges with other traders, provides relevant information in the feed, and autocopy features for successful members' trades.
  • 13.03.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.

EQS-News: SAF-HOLLAND SE with record year and significantly increased dividend proposal

Retrieved on: 
Wednesday, April 10, 2024
Annual, EUR, Annual report, Growth, Supervisory board, XETRA, Policy, Acquisition, Record, Adjustment, Investment, Film industry

In 2023, SAF-HOLLAND was able to increase Group sales by 34.6% to a new record of EUR 2,106.2 million (previous year: EUR 1,565.1 million).

Key Points: 
  • In 2023, SAF-HOLLAND was able to increase Group sales by 34.6% to a new record of EUR 2,106.2 million (previous year: EUR 1,565.1 million).
  • Adjusted EBIT increased significantly by 62.2% in the 2023 fiscal year, reaching EUR 202.1 million (previous year: EUR 124.6 million).
  • Free operating cash flow increased significantly by EUR 22.7 million compared to the previous year, from EUR 120.0 million to EUR 142.7 million.
  • In addition, the increased share of the aftermarket business should have a positive effect on margin development.

EQS-News: Advanced Blockchain AG: Portfolio Company peaq successfully raised $15 million in pre-launch funding

Retrieved on: 
Wednesday, April 10, 2024
Silencio, PEAQ, Growth, Nifedipine, XETRA, Fréchet inception distance, AB, Modularity, AI, Software development kit, Blockchain, Ecosystem, SDK, IDS, Cryptocurrency

peaq raised $15 million in a pre-launch funding round led by Generative Ventures and Borderless Capital.

Key Points: 
  • peaq raised $15 million in a pre-launch funding round led by Generative Ventures and Borderless Capital.
  • Funding will expand peaq´s ecosystem of decentralized physical infrastructure networks and support the launch of the mainnet.
  • March 28, 2024 – Advanced Blockchain AG ("AB", Scale Frankfurt, Primary Market Düsseldorf, XETRA: ISIN DE000A0M93V6), a leading incubator and investor in the blockchain industry, is excited to announce that its portfolio company peaq successfully raised $15 million in a pre-launch funding round led by Generative Ventures and Borderless Capital.
  • Both the Advanced Blockchain Management team as well as the peaq Management team will be attending the TOKEN2049 conference in Dubai next month.

EQS-News: Advanced Blockchain AG presents a strong 2023 despite a difficult market environment

Retrieved on: 
Wednesday, April 10, 2024
EUR, XETRA, Investment, AI, Cryptocurrency

March 19, 2024 – Advanced Blockchain AG ("AB", Scale Frankfurt, Primary Market Düsseldorf, XETRA: ISIN DE000A0M93V6), a leading incubator and investor in the blockchain industry, today published its preliminary figures for the past financial year 2023.

Key Points: 
  • March 19, 2024 – Advanced Blockchain AG ("AB", Scale Frankfurt, Primary Market Düsseldorf, XETRA: ISIN DE000A0M93V6), a leading incubator and investor in the blockchain industry, today published its preliminary figures for the past financial year 2023.
  • Revenue in 2023 amounted to 5.2m € in 2023 (2022: 14.7m €) and was therefore slightly above the forecast of at least 5.0m € in the 2023 half-year report.
  • With these results, Advanced Blockchain AG reached the targets for 2023 at revenue and earnings level.
  • Simon Telian, CEO of Advanced Blockchain AG, comments: “We have not disappointed our investors, even in a challenging market environment.

EQS-News: Advanced Blockchain AG: Portfolio company Composable successfully launches ETH-IBC mainnet enabling cross-chain transfers from Ethereum to Cosmos for the first time

Retrieved on: 
Wednesday, April 10, 2024
XETRA, AB, Decentralized finance, IBC, Cryptocurrency

The long-awaited launch of the ETH-IBC mainnet marks a crucial milestone for the Composable team as they now have first-mover advantage.

Key Points: 
  • The long-awaited launch of the ETH-IBC mainnet marks a crucial milestone for the Composable team as they now have first-mover advantage.
  • Rollout is scheduled in different phases, with Phase One Beta enabling asset transfers between Ethereum and Cosmos ecosystems.
  • April 4, 2024 – Advanced Blockchain AG ("AB", Scale Frankfurt, Primary Market Düsseldorf, XETRA: ISIN DE000A0M93V6), a leading incubator and investor in the blockchain industry, announces that its portfolio company Composable successfully launched their ETH-IBC mainnet.
  • As part of the mainnet beta release, the IBC connection is fully deployed to Ethereum linking the Cosmos and Ethereum Ecosystems.

EQS-News: NEON EQUITY: Investment company ELARIS successfully floated on the stock exchange

Retrieved on: 
Wednesday, April 10, 2024
EUR, EQUITY, Börse München, Frankfurt, NEON, XETRA, IPO, SUV, Security (finance)

Frankfurt am Main, March 14, 2024 - NEON EQUITY AG (NEON EQUITY ISIN: DE000A3DW408), a founder-led investor and growth enabler, has successfully advised the innovative e-mobility company ELARIS ("ELARIS", ISIN DE000A37FT17) on its IPO.

Key Points: 
  • Frankfurt am Main, March 14, 2024 - NEON EQUITY AG (NEON EQUITY ISIN: DE000A3DW408), a founder-led investor and growth enabler, has successfully advised the innovative e-mobility company ELARIS ("ELARIS", ISIN DE000A37FT17) on its IPO.
  • As of today, the shares of ELARIS are listed in the m:access trading segment of the Munich Stock Exchange.
  • In addition to the listing on the Munich Stock Exchange, a listing of the ELARIS share on XETRA is also planned in the near future.
  • Thomas Olek, founder and CEO of NEON EQUITY: "We are delighted with the successful stock market debut of ELARIS.